New diabetes drug CagriSema shows promise in Mid-Stage trial
NCT ID NCT07357740
First seen Jan 28, 2026 · Last updated May 13, 2026 · Updated 9 times
Summary
This study tests an experimental medicine, CagriSema, to see how well it lowers blood sugar in people with type 2 diabetes. About 400 adults aged 18-64 with stable diabetes will receive one of two versions of the drug, given by different injection devices. The study lasts about 38 weeks and is not yet open for enrollment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Accellacare of Duly Oak Lawn
Oak Lawn, Illinois, 60453, United States
-
Advanced Medical Research - Maumee
Maumee, Ohio, 43537, United States
-
Althaia Xarxa Assistencial Universitaria De Manresa Fundacio Privada
Manresa, 08243, Spain
-
American Research Centers of Florida
Pembroke Pines, Florida, 33027, United States
-
Arkansas Clinical Research
Little Rock, Arkansas, 72205, United States
-
Athens Medical Center S.A. (Iatriko Psychicou) - Department of Internal Medicine & Metabolic Diseases
Athens, 11525, Greece
-
CAP Alhambra
L'Hospitalet de Llobregat, 08920, Spain
-
CAPSBE_CAP Ernest LLuch
Barcelona, 08028, Spain
-
CHC Zvezdara, Clinical department for endocrinology
Belgrade, 11000, Serbia
-
Center for Diab,Obes & Metab
Pembroke Pines, Florida, 33024, United States
-
Centro Periferico De Especialidades Bola Azul
Almería, 04009, Spain
-
Centro de Salud Cabra Matrona Antonia Mesa
Cabra, 14940, Spain
-
Centro de Salud Monzón Urbano
Monzón, 22400, Spain
-
Centro de Salud Pola de Siero
Pola de Siero, 33510, Spain
-
Centro de Salud San Juan de la Cruz
Pozuelo de Alarcón, 28223, Spain
-
Clinical Centre Kragujevac, Internal Diseases Clinic, Endocrinology department
Kragujevac, 34000, Serbia
-
Clinical Res Collaborative
Cumberland, Rhode Island, 02864, United States
-
Clinical Research Associates
Nashville, Tennessee, 37203, United States
-
Clinical Site Partners Kendall Flourish Research
Miami, Florida, 33186, United States
-
Clínica Nuevas Tecnologías en Diabetes y Endocrinología
Seville, 41003, Spain
-
DIALIPID, s.r.o.
Prešov, 080 01, Slovakia
-
Diablo Clinical Research, Inc.
Walnut Creek, California, 94598, United States
-
Diakom, spol. s r.o.
Poprad, 05801, Slovakia
-
EBA Vallcarca SLP
Barcelona, 08023, Spain
-
Elevate Clinical Research
Gurnee, Illinois, 60031, United States
-
Encompass Clinical Research_Spring Valley
Spring Valley, California, 91978, United States
-
Endocrinology, Diabetes and Metabolism Diseases Clinic
Belgrade, 11000, Serbia
-
Future Medical Research
Longwood, Florida, 32750, United States
-
General Hospital Of Thessaloniki Papageorgiou - 3rd Department of Internal Medicine
Efkarpia, 564 29, Greece
-
General University Hospital Of Patras - Endocrinology Department
Pátrai, 265 04, Greece
-
Geniko Nosokomeio Thessalonikis George Papanikolaou - Internal Medicine and Diabetes Department
Thessaloniki, 570 10, Greece
-
Hope Clin Res & Wellness
Conyers, Georgia, 30094, United States
-
Hospital Kuala Lumpur
Kuala Lumpur, 50586, Malaysia
-
Hospital Melaka
Malacca, 75400, Malaysia
-
Hospital Miri
Miri, Sarawak, 98000, Malaysia
-
Hospital Seberang Jaya
Pulau Pinang, 13700, Malaysia
-
Hospital Tengku Ampuan Afzan
Kuantan, Pahang, 25100, Malaysia
-
Hospital Vall d'Hebron
Barcelona, 08035, Spain
-
Ippokratio General Hospital Of Thessaloniki - 2nd Propaedeutic Department of Internal Medicine
Thessaloniki, 546 42, Greece
-
KDCILM, LLC & Accellacare US, Inc.
Wilmington, North Carolina, 28401, United States
-
MED-DIA CENTRUM s.r.o.
Považská Bystrica, 01701, Slovakia
-
MEDIVASA, s.r.o., Diabetologicka ambulancia
Žilina, 010 01, Slovakia
-
Medrasa Clinical Research
Sherman, Texas, 75092, United States
-
New Horizon Research Center
Miami, Florida, 33165, United States
-
Paradigm Clinical Research
San Diego, California, 92108, United States
-
Phramongkutklao Hospital
Bangkok, 10400, Thailand
-
Quality Research Inc
San Antonio, Texas, 78209, United States
-
RIHES-CMU_Research Institute for Health Sciences
Chiang Mai, 50200, Thailand
-
Radiance Clinical Research
Lampasas, Texas, 76550, United States
-
Regionshospitalet Viborg - Karkirurgisk Afsnit
Viborg, 8800, Denmark
-
Sanos Clinic - Gandrup
Gandrup, 9362, Denmark
-
Sanos Clinic - Herlev
Herlev, 2730, Denmark
-
Sanos Clinic - Vejle
Vejle, Region Syddanmark, 7100, Denmark
-
Siriraj Hospital
Bangkok, 10700, Thailand
-
Songklanagarind Hospital
Songkhla, 90110, Thailand
-
Thammasat Hospital_CRC
Pathum Thani, 12120, Thailand
-
The Endocrine Center
Houston, Texas, 77079, United States
-
Thermi Clinic S.A. - Diabetes and Internal Medicine Department
Thessaloniki, 57001, Greece
-
University Clinical Centre Nis
Niš, 18 000, Serbia
-
West Orange Endocrinology
Ocoee, Florida, 34761, United States
-
iDia s. r. o.
Žiar nad Hronom, 965 01, Slovakia
Conditions
Explore the condition pages connected to this study.